| NANJING LEADS BIOLABS CO. |
| China |
| Gesundheit |
| CNE1000070H8 / A41ESB |
| 0DX (Frankfurt) |
| FRA:0DX, ETR:0DX, 0DX:GR |
| - |
| https://www.leadsbiolabs... |
|
Nanjing Leads Biolabs Co., Ltd. is a clinical-stage biotechnology company founded in 2012 and headquartered in Nanjing, China. It specializes in the discovery, development, and commercialization of innovative therapies targeting unmet needs in oncolo..
>Volltext.. |
| 1170.93 Mio. EUR |
| 1012.77 Mio. EUR |
| 21.9 Mio. EUR |
| -21.05 Mio. EUR |
| -25.74 Mio. EUR |
| -0.14 EUR |
| 35.27 Mio. EUR |
| 153.51 Mio. EUR |
| - |
| 3.08 |
| - |
| 30.17% |
| - |
| - |
| - |
| - |
| LEADS BIOLABS, LEADS BIOLABS-B |
| 24.06.26 |
|